Get Our Free Research Email
Conference Calendar 
May 20-23 - Current Concepts in Joint Replacement Spring 2012
May 23-25 - 13th EFORT Congress 2012
Complete Calendar »
|
Orthopedic and Dental Industry News
March 2006
One of the most informative sessions at AAOS was a section of the Health Policy Update Symposium delivered by William L. Healy, M.D. of the Lahey Clinic. Healy gave real-life examples of the complicated and delicate balance of hospital economics,... more
Dane Miller of Biomet called it quits a week after releasing its 3Q:06 earnings report. Last week, the Company reported earnings per share (EPS) of $0.43 which was in line with Street's estimate but did not meet analysts' expectation for... more
At AAOS last week, representatives of Exponent Inc., an engineering and scientific consulting firm, presented a study forecasting growth in the orthopedic market. Whereas our market forecast focused on revenue over the next few years, this study looks at unit... more
This morning, legendary orthopedic CEO, Dane A. Miller, Ph.D., Biomet's President and Chief Executive Officer and co-founder, announced his decision to retire. He will remain a Director and serve as a consultant. The Biomet Board has appointed Senior Vice President... more
This week at HealthpointCapital, we compiled a brief synopsis of the 2006 Orthopedic Industry, projecting that total revenue in 2006 will grow by 12% for the year. Appointment: Two notable extremities companies named their new CEOs this week: Wright Medical... more
CARLSBAD, California, March 21, 2006 /PRNewswire/ -- Alphatec Spine, Inc., ("Alphatec") today announced the appointment of four surgeons to its Scientific Advisory Board. The appointments reinforce Alphatec's commitment to becoming a leader in spinal technology, through collaboration with leading surgeon... more
Our current forecast for the orthopedic industry projects continued long term growth of 15%. For 2006, we expect growth to be slightly below this trend, at 12%. Despite continued strength in other segments of the industry, hip and knee reconstruction... more
ArthroCare Corp. has filed a notification of late filing with the Securities and Exchange Commission for its annual Form 10-K with the SEC, asking for a 15-day extension until Mar. 31, 2006. In plain engolish that means they are handing... more
On the heels of BioMimetics' approval for GEM 21S for dental use, they initiated one clinical study on GEM OS1 for distal radius fractures and two on GEM OS1 in foot and ankle fusion. GEM OS1 is a combination of... more
San Diego, CA — March 17, 2006 — Nexa Orthopedics, Inc. (“Nexa”) today announced its role in reshaping the way the extremity surgery market serves its customer. Combined with a depth of industry management experience in extremities orthopedics and a... more
Orthopedic Industry Veterans Join Growing Extremities Implant and Device Manufacturer San Diego, CA, Friday, March 17, 2006 -- Nexa Orthopedics, Inc., ("Nexa") today announced the appointment of James C. Harber as Vice President, U.S. Sales and Marketing, and Jamal D.... more
It has been a quiet week as the industry prepares for another successful AAOS annual meeting in Chicago. Since the meeting is next week, we have put together our SAB member sessions, analyst meetings, and AAOS Top Pick sessions to... more
In addition to the Top Sessions we chose, we have added AAOS presentations by our Scientific Advisory Board members. Please click on the link at the bottom to view the entire list. Wednesday, March 22 10:30 AM - 12:30 PM127Changing... more
Yesterday, President Bush nominated Dr. Andrew C. von Eschenbach as the commissioner of the Food and Drug Administratration (F.D.A.). Dr. von Eschenbach has been the acting commissioner since September 2005 when his predecessor, Lester Crawford, abruptly resigned. There was initially... more
Orthologic announced this morning that its 503-person clinical trial of its synthetic peptide Chrysalin to treat wrist fractures failed to meet its primary goal of accelerating recovery. In an instant, its market capitalization was cut in half and the company... more
Developments in ceramics has always been of great interest to participants in our industry. We thought we would alert you to this article in Wired Magazine that summarized some recent findings in ceramic technology. In essence, scientists are finding that... more
With the AAOS in Chicago fast approaching, we have put together a list of "Hot Sessions" to check out. Please click on the link at the bottom to view the entire list. Adult Reconstruction, Hip and KneeSunday, March 26, 2006... more
Tissue bank company, Tutogen Medical ("TTG"), was contacted by Zimmer's representative earlier today seeking for a possible increase in investment or acquisition. We expect that Zimmer ("ZMH") will eventually acquire all assets of TTG since ZMH CEP (formerly Centerpulse) holds... more
Although management teams are preparing for AAOS, a few more companies reported earnings this week. We did a quick calculation and found that our internal Orthopedic Index PE year-to-date has stayed relatively flat at 27x. We expect that the AAOS... more
In a very surprising trading session, LifeCell fell 13% on Tuesday after reporting a very positive 4Q:05. The Company reported that earnings totaled $0.11 per share which was in-line with analyst expectations and a 175% increase over the prior year.... more
The HealthpointCapital blog is read by thousands of people of varied backgrounds: physicians, patients, caregivers, device company employees, consultants and investors. Based on some of the feedback on the blog we see, we felt it was worth clearing up some... more
We are preparing for AAOS in Chicago, IL and invite you to check back to our website for information on analyst meetings and our top picks of scientific events happening at AAOS. Earnings: Two hip & knee orthopedic companies (Exactech,... more
The issue of patent protection is high on the minds of people in both the orthopedics industry and US business. Today the lead editorial in the Wall Street Journal (subscription required) ranted about how the patent system, designed to spur... more
Complete Archive
|
